$MRTN
MARTEN TRANSPORT LTD

2024 Q2 Form 10-Q Financial Statement

#000143774924015446 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $246.2M $249.7M $298.0M
YoY Change -13.8% -16.22% 3.74%
Cost Of Revenue $168.6M $170.1M $199.4M
YoY Change -9.79% -14.68% 4.39%
Gross Profit $77.68M $79.54M $98.61M
YoY Change -21.4% -19.34% 2.45%
Gross Profit Margin 31.54% 31.86% 33.09%
Selling, General & Admin $33.87M $32.67M $36.36M
YoY Change -3.66% -10.13% 21.5%
% of Gross Profit 43.6% 41.08% 36.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $28.21M $28.53M $29.53M
YoY Change -4.15% -3.4% 12.96%
% of Gross Profit 36.31% 35.87% 29.95%
Operating Expenses $70.23M $68.46M $74.84M
YoY Change -5.3% -8.54% -70.23%
Operating Profit $7.442M $11.08M $23.76M
YoY Change -69.83% -53.38% -33.73%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.014M $796.0K $844.0K
YoY Change -5.85% -5.69% 11957.14%
Pretax Income $10.99M $13.05M $29.85M
YoY Change -62.49% -56.3% -16.76%
Income Tax $3.099M $3.400M $7.352M
% Of Pretax Income 28.2% 26.06% 24.63%
Net Earnings $7.889M $9.646M $22.50M
YoY Change -63.93% -57.13% -18.27%
Net Earnings / Revenue 3.2% 3.86% 7.55%
Basic Earnings Per Share $0.10 $0.12 $0.28
Diluted Earnings Per Share $0.10 $0.12 $0.28
COMMON SHARES
Basic Shares Outstanding 81.36M 81.32M 81.15M
Diluted Shares Outstanding 81.45M 81.44M 81.38M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $77.20M $73.73M $96.29M
YoY Change -4.13% -23.43% 44.74%
Cash & Equivalents $77.20M $73.73M $96.29M
Short-Term Investments
Other Short-Term Assets $31.00M $24.67M $24.21M
YoY Change 6.12% 1.9% 8.18%
Inventory
Prepaid Expenses
Receivables $99.93M $105.2M $115.4M
Other Receivables $11.45M $10.38M $7.988M
Total Short-Term Assets $219.6M $214.0M $243.9M
YoY Change -5.34% -12.25% 10.85%
LONG-TERM ASSETS
Property, Plant & Equipment $788.8M $777.5M $733.7M
YoY Change 2.37% 5.97% 10.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.520M $1.499M $1.641M
YoY Change -5.3% -8.65% 6.21%
Total Long-Term Assets $790.3M $779.0M $735.4M
YoY Change 2.36% 5.93% 10.52%
TOTAL ASSETS
Total Short-Term Assets $219.6M $214.0M $243.9M
Total Long-Term Assets $790.3M $779.0M $735.4M
Total Assets $1.010B $993.0M $979.3M
YoY Change 0.58% 1.4% 10.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $47.21M $37.73M $41.56M
YoY Change 30.76% -9.22% 42.53%
Accrued Expenses $27.47M $29.42M $29.08M
YoY Change -41.87% 1.17% -22.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $119.0M $111.4M $119.6M
YoY Change -9.19% -6.82% 9.34%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $220.0K $202.0K $335.0K
YoY Change -28.34% -39.7% -0.3%
Total Long-Term Liabilities $220.0K $202.0K $335.0K
YoY Change -28.34% -39.7% -0.3%
TOTAL LIABILITIES
Total Short-Term Liabilities $119.0M $111.4M $119.6M
Total Long-Term Liabilities $220.0K $202.0K $335.0K
Total Liabilities $243.1M $230.6M $257.8M
YoY Change -7.93% -10.54% 8.93%
SHAREHOLDERS EQUITY
Retained Earnings $714.6M $711.5M $673.5M
YoY Change 3.48% 5.64% 14.61%
Common Stock $52.20M $50.88M $47.96M
YoY Change 5.5% 6.08% -21.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $766.8M $762.4M $721.5M
YoY Change
Total Liabilities & Shareholders Equity $1.010B $993.0M $979.3M
YoY Change 0.58% 1.4% 10.6%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $7.889M $9.646M $22.50M
YoY Change -63.93% -57.13% -18.27%
Depreciation, Depletion And Amortization $28.21M $28.53M $29.53M
YoY Change -4.15% -3.4% 12.96%
Cash From Operating Activities $35.82M $45.72M $49.23M
YoY Change -26.85% -7.13% 23.26%
INVESTING ACTIVITIES
Capital Expenditures $65.36M $30.28M $44.46M
YoY Change -16.36% -31.89% -473.08%
Acquisitions
YoY Change
Other Investing Activities $37.58M $49.00K $45.00K
YoY Change 111.35% 8.89% 18.42%
Cash From Investing Activities -$27.78M -$20.25M -$28.28M
YoY Change -53.98% -28.4% -7014.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.576M -$4.956M -$5.264M
YoY Change 4.71% -5.85% -82.92%
NET CHANGE
Cash From Operating Activities 35.82M $45.72M $49.23M
Cash From Investing Activities -27.78M -$20.25M -$28.28M
Cash From Financing Activities -4.576M -$4.956M -$5.264M
Net Change In Cash 3.469M $20.52M $15.69M
YoY Change -122.01% 30.78% 64.58%
FREE CASH FLOW
Cash From Operating Activities $35.82M $45.72M $49.23M
Capital Expenditures $65.36M $30.28M $44.46M
Free Cash Flow -$29.54M $15.44M $4.768M
YoY Change 1.25% 223.8% -90.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000799167
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2024Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0 usd
CY2024Q1 mrtn Customer Contract Term
CustomerContractTerm
P1Y
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 pure
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
5 pure
CY2022Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2022Q3 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2023 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2024Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
88762000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
98516000 usd
CY2024Q1 mrtn Purchased Transportation
PurchasedTransportation
41814000 usd
CY2023Q1 mrtn Purchased Transportation
PurchasedTransportation
54103000 usd
CY2024Q1 mrtn Fuel And Fuel Tax Expense
FuelAndFuelTaxExpense
39561000 usd
CY2023Q1 mrtn Fuel And Fuel Tax Expense
FuelAndFuelTaxExpense
46796000 usd
CY2024Q1 mrtn Supplies And Maintenance Expense
SuppliesAndMaintenanceExpense
16070000 usd
CY2023Q1 mrtn Supplies And Maintenance Expense
SuppliesAndMaintenanceExpense
15987000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
28527000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
29530000 usd
CY2024Q1 us-gaap Taxes And Licenses
TaxesAndLicenses
2575000 usd
CY2023Q1 us-gaap Taxes And Licenses
TaxesAndLicenses
2768000 usd
CY2024Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
11657000 usd
CY2023Q1 us-gaap General Insurance Expense
GeneralInsuranceExpense
15070000 usd
CY2024Q1 mrtn Communications And Utilities Expense
CommunicationsAndUtilitiesExpense
2371000 usd
CY2023Q1 mrtn Communications And Utilities Expense
CommunicationsAndUtilitiesExpense
2531000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
1171000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
5246000 usd
CY2024Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7256000 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8958000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
237422000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
269013000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12250000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29010000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
796000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
844000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13046000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29854000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3400000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7352000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
9646000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22502000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.06
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
703919000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22502000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
536000 usd
CY2023Q1 mrtn Adjustments To Additional Paid In Capital Employee Taxes Paid In Exhange For Shares Witheld
AdjustmentsToAdditionalPaidInCapitalEmployeeTaxesPaidInExhangeForSharesWitheld
926000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
354000 usd
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4874000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
721511000 usd
us-gaap Net Income Loss
NetIncomeLoss
47871000 usd
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
674000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1965000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14635000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
757386000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
9646000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
307000 usd
CY2024Q1 mrtn Adjustments To Additional Paid In Capital Employee Taxes Paid In Exhange For Shares Witheld
AdjustmentsToAdditionalPaidInCapitalEmployeeTaxesPaidInExhangeForSharesWitheld
-382000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
353000 usd
CY2024Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
4881000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
762429000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
9646000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22502000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
28527000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
29530000 usd
CY2024Q1 mrtn Amortization Expense For Tires In Service
AmortizationExpenseForTiresInService
1763000 usd
CY2023Q1 mrtn Amortization Expense For Tires In Service
AmortizationExpenseForTiresInService
1765000 usd
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3516000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
784000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
353000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
354000 usd
CY2024Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-6025000 usd
CY2023Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-9135000 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1810000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2232000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2197000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6691000 usd
CY2024Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
-2720000 usd
CY2023Q1 us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
3220000 usd
CY2024Q1 mrtn Increase Decrease In Accrued Other Current Liabilities
IncreaseDecreaseInAccruedOtherCurrentLiabilities
2808000 usd
CY2023Q1 mrtn Increase Decrease In Accrued Other Current Liabilities
IncreaseDecreaseInAccruedOtherCurrentLiabilities
-8353000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45722000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
49232000 usd
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
49000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
45000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20249000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28280000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4881000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4874000 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
307000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
536000 usd
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
382000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
926000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4956000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5264000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20517000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15688000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
53213000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
80600000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
73730000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
96288000 usd
CY2024Q1 mrtn Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-6780000 usd
CY2023Q1 mrtn Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
2561000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
22000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
9646000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
22502000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81350000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81210000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
87000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
166000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81437000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81376000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.28
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.28
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
30000000 usd
CY2024Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
20700000 usd
CY2024Q1 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
9300000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
20700000 usd
CY2023Q4 mrtn Line Of Credit Facility Dividends Payment Maximum
LineOfCreditFacilityDividendsPaymentMaximum
150000000 usd
CY2019Q3 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
34000000 usd
CY2019Q3 srt Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1800000
CY2020Q3 srt Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
2700000
CY2022Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
CY2022Q2 srt Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
3100000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1300000
CY2022Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
25000000 usd
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
963000
CY2022Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
16800000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
33200000 usd
CY2024Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
2200000
CY2024Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
353000 usd
CY2023Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
354000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
485000 usd
CY2024Q1 us-gaap Revenues
Revenues
249672000 usd
CY2023Q1 us-gaap Revenues
Revenues
298023000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
12250000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
29010000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001437749-24-015446-index-headers.html Edgar Link pending
0001437749-24-015446-index.html Edgar Link pending
0001437749-24-015446.txt Edgar Link pending
0001437749-24-015446-xbrl.zip Edgar Link pending
ex_661378.htm Edgar Link pending
ex_661379.htm Edgar Link pending
ex_661380.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrtn-20240331.xsd Edgar Link pending
mrtn20240331_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
mrtn-20240331_cal.xml Edgar Link unprocessable
mrtn-20240331_def.xml Edgar Link unprocessable
mrtn-20240331_lab.xml Edgar Link unprocessable
mrtn-20240331_pre.xml Edgar Link unprocessable
mrtn20240331_10q_htm.xml Edgar Link completed